Hello hard working brokers!
In my continued effort to educate and inform, here is more information about what employers are doing (fighting) for data that shows how their health plans overpay for care. Please click on this Bloomberg news report released today to learn more.
This second article is about the expensive diabetic drug Ozempic/Wecovy, that is being used as a weight-loss drug. It’s an expensive drug and how employers are cutting off access for use of weight loss for workers.
Let me know your thoughts on these articles. Self-funding is solving this problem! Let me know how we can help. Have a great day
Heidi Hina
Vice President of Business Development
e. hhina@wellnet.com
m. 281-687-2388
Request An Appt: https://calendly.com/hhina
LinkedIN: https://www.linkedin.com/in/heidihina/
